Will CRISPR fears fade with familiarity?
By Patricia Stapleton,
The Conversation
| 08. 21. 2017
The first “test-tube baby” made headlines around the world in 1978, setting off intense debate on the ethics of researching human embryos and reproductive technologies. Every breakthrough since then has raised the same questions about “designer babies” and “playing God” – but public response has grown more subdued rather than more engaged as assisted reproductive technologies have become increasingly sophisticated and powerful.
As the science has advanced, doctors are able to perform more complex procedures with better-than-ever success rates. This progress has made in vitro fertilization and associated assisted reproductive technologies relatively commonplace. Over one million babies have been born in the U.S. using IVF since 1985.
And Americans’ acceptance of these technologies has evolved alongside their increased usage, as we’ve gotten used to the idea of physicians manipulating embryos.
But the ethical challenges posed by these procedures remain – and in fact are increasing along with our capabilities. While still a long way from clinical use, the recent news that scientists in Oregon had successfully edited genes in a human embryo brings us...
Related Articles
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Dalton Conley, The New York Times | 03.13.2025
Since Francis Galton coined the phrase “nature versus nurture” 150 years ago, the debate about what makes us who we are has dominated the human sciences.
Do genes determine our destiny, as the hereditarians would say? Or do we enter...
By Staff, The Medicine Maker | 03.21.2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later...
By Carter Sherman, The Guardian | 03.11.2025
In his first address to the United States after becoming vice-president, JD Vance stood on stage and proclaimed: “I want more babies in the United States of America.” Weeks later, Donald Trump signed an executive order pledging support for in...